id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2013-E-1302-0007,FDA,FDA-2013-E-1302,Letter from U.S. Patent and Trademark Office,Other,Letter(s),2016-12-29T05:00:00Z,2016,12,2016-12-29T05:00:00Z,,2016-12-29T17:19:45Z,,0,0,090000648243dfb6
FDA-2013-E-1302-0006,FDA,FDA-2013-E-1302,Letter from FDA CDER to the U.S. Patent and Trademark Office,Other,Letter(s),2015-12-01T05:00:00Z,2015,12,2015-12-01T05:00:00Z,,2015-12-01T17:29:55Z,,0,0,0900006481d7d98c
FDA-2013-E-1302-0005,FDA,FDA-2013-E-1302,"Determination of Regulatory ReviewCPeriod for Purposes of Patent
Extension; CAMERON HEALTH S–ICD SYSTEM",Notice,Determinations,2015-05-04T04:00:00Z,2015,5,2015-05-04T04:00:00Z,,2015-05-04T14:02:28Z,2015-10334,0,0,0900006481acb040
FDA-2013-E-1302-0004,FDA,FDA-2013-E-1302,Letter from FDA CDER to the U.S. Patent and Trademark Office,Other,Letter(s),2015-04-22T04:00:00Z,2015,4,2015-04-22T04:00:00Z,,2015-04-22T20:22:55Z,,0,0,0900006481ab4ee3
FDA-2013-E-1302-0003,FDA,FDA-2013-E-1302,Letter from FDA CDER to U.S. Patent and Trademark Office,Other,Letter(s),2014-03-19T04:00:00Z,2014,3,2014-03-19T04:00:00Z,,2014-03-19T16:30:09Z,,0,0,090000648166fbd9
FDA-2013-E-1302-0002,FDA,FDA-2013-E-1302,"Carmeron Health, Inc. (PRAMUDJI LAW GROUP PLLC) - Patent Extension Application",Other,Application,2013-10-21T04:00:00Z,2013,10,2013-10-21T04:00:00Z,,2013-10-21T16:19:23Z,,0,0,0900006481456bda
FDA-2013-E-1302-0001,FDA,FDA-2013-E-1302,U.S. Patent and Trademark Office - Letter,Other,Letter(s),2013-10-21T04:00:00Z,2013,10,2013-10-21T04:00:00Z,,2013-10-21T16:19:23Z,,0,0,0900006481456bd8